# GBL to acquire co-controlling stake in Rayner from CVC

GBL will invest €0.5 billion to acquire a co-controlling minority stake in Rayner, a global leader in surgical ophthalmology, from CVC Capital Partners VIII. The transaction was announced on February 9, 2026.

- Type: Acquisition
- Announced: 2026-02-09
- Value: $540.0M (500.0M EUR)
- Status: announced
- Products: intraocular lenses, ophthalmic consumables, phaco platform
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [CVC Capital Partners](https://endata.com/companies/226.md) (partner)
- [Rayner](https://endata.com/companies/33328.md) (target)
- [GBL](https://endata.com/companies/90215.md) (acquirer)

## Sources

- [cvc.com](https://www.cvc.com/media/news/2026/gbl-to-invest-in-rayner-alongside-cvc-to-support-growth-acceleration/), 2026-02-09: "This transaction marks an exciting milestone for Rayner."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.